Aave remains the largest decentralized lending platform in DeFi with about $28 billion in deposits as of early November 2026, split between $16.2 billion unused liquidity and $11.8 billion lent out. The protocol operates via smart contracts without banks, requiring over-collateralization to secure loans and using a health factor to trigger liquidations if collateral value drops. Despite its size, Aave faced a liquidity crisis in April 2026 triggered by issues with the rsETH token, causing a sharp drop in total value locked from $26.4 billion to $14.3 billion. The platform also introduced Aave V4 and its own stablecoin GHO, but risks remain from smart contract bugs, liquidation events, and collateral vulnerabilities. In Germany, Aave operates without a BaFin license under MiCA exemptions, and tax treatment distinguishes between AAVE token gains and interest income from lending. Investors should approach with caution, understanding the risks and regulatory landscape.
The story about Aave and its DeFi lending platform is presented with market context from Pluang as of Nov 09, 2026 20:02 WIB. For readers following major cryptocurrencies, 17 out of 50 priced assets rose and 32 fell today on Pluang. Notable movers include EOS at Rp12.649 with an 8.13% increase and ZIL at Rp32 with a 6.64% rise, while XRP dropped 5.09% to Rp19.958. EOS showed a typical hold time of 87 days, and ZIL had a Pluang order activity skewed 74% sell to 26% buy.
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
